← Leaderboards
Veerle Bergink
Icahn School Of Medicine At Mount Sinai
$7,943,611
Attributed
$8,639,679
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,639,679 · 4
By mechanism
R01$7,247,543 · 2
R34$979,328 · 1
R21$412,808 · 1
Top collaborators
- Moriah E Thomason4 shared
- Lotje Dorothee De Witte1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Behrang Mahjani$1,309,667
- Holly Loudon$8,065
Others in their field
Other Emerging Leaders on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Jorge Eduardo Chavarro · Harvard School Of Public Health$13,845,291
- Tomasz Nowakowski · University Of California, San Francisco$13,203,364
- Barney Sparrow · Battelle Memorial Institu$13,048,137
- Magdalena Zernicka-Goetz · California Institute Of Technology$11,182,591
- Sara Bonamo Demauro · Children'S Hosp Of Philadelphia$11,044,839
Research focus
PregnancyPregnant WomenChildOffspringBirthFetusLong-Term EffectsSample SizePrenatalBipolar DisorderSamplingBrainExposure ToReportingSchizophreniaSeveritiesNeurodevelopmentBehavioralFamilyResourcesGestational AgeMagnetic Resonance ImagingMental HealthCognitive
Grant awards (17)
Relapse after Discontinuation of Antipsychotics during Pregnancy (R-DAP study)$674,927
R01 · FY2025 · MH · contact PI
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence$588,183
R01 · FY2025 · MH · contact PI
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence$143,589
R01 · FY2025 · MH · contact PI
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence$746,306
R01 · FY2024 · MH · contact PI
Relapse after Discontinuation of Antipsychotics during Pregnancy (R-DAP study)$695,417
R01 · FY2024 · MH · contact PI
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence$671,674
R01 · FY2023 · MH · contact PI
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)$551,973
R01 · FY2023 · MH · contact PI
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence$708,989
R01 · FY2022 · MH · contact PI
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)$551,973
R01 · FY2022 · MH · contact PI
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence$773,290
R01 · FY2021 · MH · contact PI
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)$547,142
R01 · FY2021 · MH · contact PI
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)$228,933
R34 · FY2021 · DA
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)$594,080
R01 · FY2020 · MH · contact PI
EXPOSURE TO TETRACYCLINE ANTIBIOTICS AND THE POTENTIAL PROTECTIVE EFFECT ON SCHIZOPHRENIA RISK.$412,808
R21 · FY2020 · MH · contact PI
1/7: Longitudinal evaluation of the impact of the COVID-19 pandemic on high-risk new and expectant mothers$186,462
R34 · FY2020 · DA
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)$281,967
R34 · FY2019 · DA
4:4 Investigation of opioid exposure and neurodevelopment (iOPEN)$281,966
R34 · FY2019 · DA